Although
estrogen receptor (ER)α agonists, such as
estradiol and ethinylestradiol (EE2), cause
cholestasis in mice, they also reduce the degree of liver injury caused by hepatotoxicants as well as
ischemia-reperfusion. The functional mechanisms of ERα have yet to be elucidated in
drug-induced or chemical-induced liver injury. The present study investigated the effects of an ERα agonist, selective ER modulators (
SERMs) and an ER antagonist on
drug-induced and chemical-induced liver
injuries caused by
acetaminophen,
bromobenzene,
diclofenac, and
thioacetamide (TA). We observed hepatoprotective effects of EE2,
tamoxifen (TAM) and
raloxifene pretreatment in female mice that were exposed to a variety of hepatotoxic compounds. In contrast, the ER antagonist did not show any hepatoprotective effects.
DNA microarray analyses suggested that monocyte to macrophage differentiation-associated 2 (Mmd2)
protein, which has an unknown function, is commonly increased by TAM and RAL pretreatment, but not by pretreatment with the ER antagonist. In ERα-knockout mice, the hepatoprotective effects of TAM and the increased expression of Mmd2
mRNA were not observed in TA-induced liver injury. To investigate the function of Mmd2, the expression level of Mmd2
mRNA was significantly knocked down to approximately 30% in mice by injection of
siRNA for Mmd2 (siMmd2). Mmd2 knockdown resulted in a reduction of the protective effects of TAM on TA-induced liver injury in mice. This is the first report of the involvement of ERα in
drug-induced or chemical-induced liver injury. Upregulation of Mmd2
protein in the liver was suggested as the mechanism of the hepatoprotective effects of EE2 and
SERMs.